📰 Services Task Force News
Page 42 - Services Task Force News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Services Task Force. Real-time updates on events, politics, business and more.
May 26, 2024
National panels have released new guidance for breast cancer screenings, but some people are finding out that insurance companies don't cover them all
May 24, 2024
Among younger women with breast cancer, it may be possible for many to have a baby after their diagnosis, new research suggests.
May 24, 2024
CBS 58 is your local source for the Milwaukee news, Milwaukee weather, and Milwaukee sports.
May 23, 2024
A 5-year interval between cervical cancer screenings using HPV testing does not increase risk for cervical precancer detection compared with cytology every 3 years and may be a more effective screening method long term, researchers report.The U.S. has gradually transitioned from cytology to HPV-based screening for cervical cancer over the past 20 years, according to Anna Gottschlich, PhD, MPH,
May 23, 2024
The test would not replace any screening methods, but it could be another noninvasive option, to boost the number of people who complete screenings.
May 23, 2024
With rates of cancer soaring among young people, doctors are pleading with people to use simple tests that can be done at home, which saved the life of actress Olivia Munn.
May 22, 2024
HPV testing to prevent cervical cancer might not have to happen as often as currently recommended, a new study says.
May 22, 2024
Lunit, a provider of Artificial intelligence (AI)-powered solutions for cancer diagnostics and therapeutics, today announced the successful completion of its acquisition of Volpara Health Technologies Ltd., a global developer of medical software for breast cancer screening. The landmark acquisition was completed in an eight-month timeline, and will advance cancer diagnostics and care, according to the Seoul, South Korea-based company.
May 22, 2024
Over the past two decades, the United States has been transitioning from cytology to HPV-based screening for cervical cancer. The U.S. Preventive Services Task Force currently recommends one of three options for routine cervical cancer screening: 1) cytology screening every three years; 2) HPV screening every five years; or 3) co-testing in which both an HPV and cytology screening are conducted every five years.
May 22, 2024
"Unsure about colonoscopy guidelines? Rising colorectal cancer rates spark debate on recommended screening age and interval in the U.S."